Back
Celldex Therapeutics Quote, Financials, Valuation and Earnings
7 Powerhouse Stocks to Buy and Hold Forever
Get it now.
Buy
58
CLDX
Celldex Therapeutics
Last Price:
40.87
Seasonality Move:
8.17%
7 Day Trial
ALL ACCESS PASS
$
7
Master the Market: The Formula for a 96.3% Win Rate Revealed!
Act now!Celldex Therapeutics Price Quote
$40.87
+1.54 (+3.92%)
(Updated: May 2, 2024 at 6:55 PM ET)
Celldex Therapeutics Key Stats
Buy
58
Celldex Therapeutics (CLDX)
is a Buy
Day range:
$37.45 - $40.88
52-week range:
$22.11 - $53.18
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
276.84
P/B ratio:
5.12%
Volume:
737.4K
Avg. volume:
641.7K
1-year change:
25.45%
Market cap:
$2.2B
Revenue:
$6.9M
EPS:
$-2.92
How Much Does Celldex Therapeutics Make?
-
How Much Are Celldex Therapeutics's Sales Annually?
CLDX Revenues are $6.9M -
How Much Profit Does Celldex Therapeutics's Make A Year?
CLDX net income is -$141.4M
Is Celldex Therapeutics Growing As A Company?
-
What Is Celldex Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is 1.56% -
What Is Celldex Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Celldex Therapeutics Stock Price Performance
-
Did Celldex Therapeutics Stock Go Up Last Month?
Celldex Therapeutics share price went down by -5.55% last month -
Did CLDX's Share Price Rise Over The Last Year?
CLDX share price rose by 25.45% over the past 1 year
What Is Celldex Therapeutics 52-Week High & Low?
-
What Is Celldex Therapeutics’s 52-Week High Share Price?
Celldex Therapeutics has traded as high as $53.18 over the past 52 weeks -
What Is Celldex Therapeutics’s 52-Week Low Share Price?
Celldex Therapeutics has traded as low as $22.11 over the past 52 weeks
Celldex Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Celldex Therapeutics?
-
How Much Debt Does Celldex Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Celldex Therapeutics Have?
Cash and short term investments quarterly total is $423.6M -
What Is Celldex Therapeutics’s Book Value Per Share?
Book value per share is 7.68
Is Celldex Therapeutics Cash Flow Positive?
-
What Is CLDX Cash Flow From Operations?
Cash flow from operations (TTM) is -$107.3M -
What Is Celldex Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $218.5M -
What Is Celldex Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$105.8M
Celldex Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
CLDX return on invested capital is -44.69% -
What Is Celldex Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -41.06% -
What Is CLDX Return On Equity?
ROE is a measure of profitability and is -44.69%
Celldex Therapeutics Earnings Date & Stock Price
-
What Is Celldex Therapeutics's Stock Price Today?
A single share of CLDX can be purchased today for 39.33 -
What Is Celldex Therapeutics’s Stock Symbol?
Celldex Therapeutics trades on the nasdaq under the ticker symbol: CLDX -
When Is Celldex Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Celldex Therapeutics is scheduled on May 3, 2024 -
When Is CLDX's next ex-dividend date?
Celldex Therapeutics's next ex-dividend date is May 16, 2020 -
How To Buy Celldex Therapeutics Stock?
You can buy Celldex Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Celldex Therapeutics Competitors
-
Who Are Celldex Therapeutics's Competitors?
Below is a list of companies who compete with Celldex Therapeutics or are related in some way:
Celldex Therapeutics Dividend Yield
Data Unavailable
Celldex Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 11.63% |
| Revenue: | 156.11% | 382.87% |
Analyst Recommendations
| Buy Recommendations: | 6 |
|---|---|
| Hold Recommendations: | 1 |
| Sell Recommendations: | 0 |
| Price Target: | 70.71 |
| Upside from Last Price: | 79.8% |